-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Olivia Carr
Olivia was the Summer 2012 intern for the Communications Department at BIO.
Latest Posts
New Rare Disease Miniseries
Calling all biopharma researchers! Morning show “The Balancing Act” is producing a miniseries called “Roulette Wheel of Rare and Genetic Diseases,” and they are looking for pharmaceutical partners to help educate their audience. The series is working with the Global Genes Project to help educate patients and their families about new research, clinical trials, and government policies that affect those with a rare disease. Patient groups are already excited about this opportunity to spread awareness- take Read More >
2012 Fall Event Preview
The 2012 BIO International Convention, the global event for biotechnology, held at the Boston Convention & Exhibition Center in Boston, Mass., wrapped this June. The event hosted a record 25,291 partnering meetings and highlighted a broad array of top-level speakers addressing critical global challenges and the top issues in biotechnology. Hosted by the Biotechnology Industry Organization (BIO), the event drew 16,505 industry leaders from 49 states and 65 countries. See what BIO President and CEO Jim Greenwood Read More >
Learning the Truth About Clinical Trials
There are currently over 60,000 clinical trials occurring in the United States. These programs not only allow patients to access potentially ground-breaking new therapies, but also help researchers collect valuable data. Many patients have concerns about the risk involved, despite the importance of clinical trials in the drug development process. Common misperceptions can deter patients from seeking out new approaches to treatment that can currently only be found in clinical trials. The Masonic Cancer Center Read More >
Silk Improves Vaccine Longevity
Who doesn’t love the feel of silk fabric? Dresses, ties, sofa upholstery- you name it, we can’t keep our hands off it. You may have also heard that silk is an excellent surgical material for sutures, bandages, and implants. But did you know that our favorite fiber may not only patch up the world, but heal it as well? Here’s the problem we face: Many vaccines need to be kept cold in order to work Read More >
ASBMB and the 2012 Diversity Summit
BIO is glad to hear that the American Society for Biochemistry and Molecular Biology (ASBMB) is helping the biotech community by promoting diversity. ASBMB has put forth a number of recommendations in response to an alarming 2011 NIH study showing that black researchers were 10% less likely to receive funding than white researchers. These suggestions all aim to ease access to resources and educate minority scientists on how to succeed in the research community- read Read More >
